All companies
Visit website
Waverly Labs
OperatingWaverly Labs Inc
Healthcare · Founded 2014
Post-money valuation ⓘ
$42.2M
As of Sep 2022 · from Waverly Labs Common Stock 3 · pre-money + amount raised, not a traded price
Total raised
$4,479,392
Across 4 rounds since 2017
Latest share price
$9.78
Waverly Labs Common Stock 3 offering price
Financials
FY2015–FY2021 · from SEC filings · hover any figure for its source$0
−$6K
2015
$0
2016
$899K
−$1.6M
2017
$6.6M
$3.2M
2018
$456K
−$1.1M
2019
$423K
−$1.1M
2020
$832K
−$1.2M
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
Income statement
Revenue
$0
$0
$899,240
$6,589,250
$456,114
$423,312
$832,033
Cost of goods sold
$0
$0
$421,164
$3,314,323
-$383,429
$348,510
$631,479
Gross margin
—
—
53%
50%
16%
18%
24%
Net income
-$6,125
$0
-$1,596,393
$3,189,128
-$1,054,935
-$1,135,320
-$1,246,760
Taxes paid
$0
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$448
$3,038,451
$2,748,290
$587,825
$408,658
$163,780
$642,340
Accounts receivable
$0
$0
$0
$0
$0
$0
$5,557
Total assets
$448
$3,157,967
$3,661,728
$880,503
$848,890
$627,242
$1,186,593
Short-term debt
$9,000
$0
$6,205,667
$76,938
$0
$113,220
$40,107
Long-term debt
$0
$0
$0
$0
$0
$101,845
$496,335
Total liabilities
$9,000
$0
$6,205,667
$76,938
$616,087
$215,065
$536,442
Other
Headcount
—
10
4
10
10
3
10
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$12.5M
post-money
$15.1M
post-money
$42.2M
post-money
$42.2M
post-money
Waverly Stock 1
Waverly Stock 2
Waverly Stock 3
Waverly Labs Common Stock 3
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $136.5K / $1.2MInvestors 147Post-money $42.2M
Raised $2.2M / $10MInvestors 1,567Post-money $42.2M
Waverly Stock 2Closed
Reg CF annual-report compliance
Not required3+ reports filed & assets ≤ $10M
Filed 5 of 9 annual reports (FY2017–FY2025)
1,567 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 27 filings on EDGARSource: ManualCIK 0001720044Share price $9.78
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.